These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
99 related articles for article (PubMed ID: 1530414)
1. [Elements of choice of thrombolytic agents in myocardial infarction]. Samama M; Brochet E; Valère PE Arch Mal Coeur Vaiss; 1992 May; 85(5 Suppl):721-7. PubMed ID: 1530414 [TBL] [Abstract][Full Text] [Related]
2. [New thrombolytic agents in myocardial infarction]. Charbonnier B; Lang M; Brochier M Arch Mal Coeur Vaiss; 1987 Nov; 80(12):1785-91. PubMed ID: 3128222 [TBL] [Abstract][Full Text] [Related]
3. New developments in thrombolytic therapy. Collen D; Gold HK Verh K Acad Geneeskd Belg; 1989; 51(3):191-228; discussion 229. PubMed ID: 2686261 [TBL] [Abstract][Full Text] [Related]
4. [Arterial permeability, objective of thrombolytic therapy]. Bassand JP; Schiele F; Bernard Y; Anguenot T Arch Mal Coeur Vaiss; 1992 May; 85(5 Suppl):677-87. PubMed ID: 1530409 [TBL] [Abstract][Full Text] [Related]
5. [t-PA in thrombolytic therapy of acute myocardial infarct]. Rutsch W; Schmutzler H Herz; 1994 Dec; 19(6):336-52. PubMed ID: 7843690 [TBL] [Abstract][Full Text] [Related]
6. New developments in thrombolytic therapy. Collen D; Gold HK Adv Exp Med Biol; 1990; 281():333-54. PubMed ID: 2129372 [TBL] [Abstract][Full Text] [Related]
7. [Thrombolytic treatment during the acute phase of myocardial infarction. An important reduction of early and secondary mortality]. Charbonnier B Arch Mal Coeur Vaiss; 1992 May; 85(5 Suppl):697-705. PubMed ID: 1530411 [TBL] [Abstract][Full Text] [Related]
8. [Myocardial infarction treated within 4 hrs: comparison of the cost-benefit ratio of 3 thrombolytic treatments: APSAC, rt-PA and streptokinase in 270 patients]. Machecourt J; Cassagnes J; Bassand JP; Dumoulin J; Calop J; Foroni L; Terrisse MP; Hénon T; Petit L; Denis B Arch Mal Coeur Vaiss; 1993 Feb; 86(2):209-17. PubMed ID: 8363422 [TBL] [Abstract][Full Text] [Related]
9. [Thrombolytic drugs in acute myocardial infarct]. Ambrosioni E; Degli Esposti D Cardiologia; 1991 Dec; 36(12 Suppl 1):395-402. PubMed ID: 1841796 [TBL] [Abstract][Full Text] [Related]
14. [Thrombolytic therapy of myocardial infarction: practical management]. Bonnet JL; Bory M Arch Mal Coeur Vaiss; 1992 May; 85(5 Suppl):707-12. PubMed ID: 1530412 [TBL] [Abstract][Full Text] [Related]
15. Streptokinase and rt-PA activate platelets by a different way: implications on the rethrombosis rate after their administration in myocardial infarction. Parise P; Hauert J; Iorio A; Callegari P; Agnelli G J Lab Clin Med; 1995 Feb; 125(2):212-21. PubMed ID: 7531212 [TBL] [Abstract][Full Text] [Related]
16. [Platelet activation in the early phases of acute myocardial infarction]. Salvioni A; Giraldi F; Assanelli E; Lauri G; Grazi M; Pardea S; Marenzi G Cardiologia; 1998 Aug; 43(8):825-32. PubMed ID: 9808873 [TBL] [Abstract][Full Text] [Related]
17. New developments in thrombolytic therapy. Collen DC; Gold HK Thromb Res Suppl; 1990; 10():105-31. PubMed ID: 2180114 [TBL] [Abstract][Full Text] [Related]
18. Combinations of thrombolytic agents in acute myocardial infarction. Bode C; Baumann H; von Hodenberg E; Freitag M; Nordt T Z Kardiol; 1993; 82 Suppl 2():125-8. PubMed ID: 8328189 [TBL] [Abstract][Full Text] [Related]